Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M105Revenue (TTM) $M56.1Net Margin (%)-133.1Altman Z-Score-30.5
Enterprise Value $M46.2EPS (TTM) $-0.4Operating Margin %-130.2Piotroski F-Score3
P/E(ttm)--Beneish M-Score-1.8Pre-tax Margin (%)-135.7Higher ROA y-yY
Price/Book2.510-y EBITDA Growth Rate %-56.2Quick Ratio2.1Cash flow > EarningsN
Price/Sales1.75-y EBITDA Growth Rate %-31.4Current Ratio2.2Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-74.4Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-328.4Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M283ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with CTIC

Number of guru portfolios checked: 68.
No Entry found in the selected group of Gurus. You can

CTIC is held by these investors:

No Entry found in the selected group of Gurus. You can
Premium Most recent portfolio changes are included for Premium Members only!


CTIC: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
BIANCO JAMES APresident and CEO 2016-06-24Sell10,000$0.370view
BIANCO JAMES APresident and CEO 2016-05-27Sell10,000$0.45-17.78view
BIANCO JAMES APresident and CEO 2016-04-29Sell10,000$0.52-28.85view
BIANCO JAMES APresident and CEO 2016-03-28Sell10,000$0.49-24.49view
BIANCO JAMES APresident and CEO 2016-03-21Sell318,169$0.55-32.73view
Plunkett MatthewEVP, Chief Business Officer 2016-03-04Sell10,000$0.59-37.29view
BIANCO JAMES APresident and CEO 2016-02-26Sell10,000$0.63-41.27view
SINGER JACK WEVP, Chief Scientific Officer 2016-02-26Sell15,000$0.63-41.27view
BIANCO JAMES APresident and CEO 2016-02-16Sell100,000$0.42-11.9view
Plunkett MatthewEVP, Chief Business Officer 2016-02-04Sell10,000$1.15-67.83view

Press Releases about CTIC :

Quarterly/Annual Reports about CTIC:

News about CTIC:

Articles On GuruFocus.com
Monday Morning Pre-Market Insights: Celldex Therapeutics, Celladon Corp, CTI BioPharma Corp, TG Ther Jun 01 2015 
Weekly CEO Sells Highlight: Groupon Inc., Cell Therapeutics Inc., Standard Pacific Corp and Dollar G Mar 24 2014 
These 4 Biotech Stocks Are a Buy Now Feb 08 2012 
Cell Therapeutics Inc. (CTIC) CEO James A Bianco sells 50,000 Shares Feb 25 2011 
Cell Therapeutics Inc. (CTIC) CEO James A Bianco sells 50,000 Shares Jan 28 2011 
Weekly CEO Sells Highlight: CTIC, DDR, UNM, BRCM, TC Jan 09 2011 
Cell Therapeutics Inc. (CTIC) CEO James A Bianco sells 250,000 Shares Jan 03 2011 
Cell Therapeutics Inc. (CTIC) CEO James A Bianco sells 200,000 Shares Dec 17 2010 
Cell Therapeutics Inc. (CTIC) CEO James A Bianco sells 150,000 Shares Dec 10 2010 
Cell Therapeutics Inc. (CTIC) CEO James A Bianco sells 100,000 Shares Nov 05 2010 

More From Other Websites
CTI BIOPHARMA CORP Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD... Sep 29 2016
CTI BioPharma Granted 180 Day Extension By NASDAQ To Regain Compliance With Minimum Bid Price Rule Sep 22 2016
CTI BIOPHARMA CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial... Sep 19 2016
CTI BIOPHARMA CORP Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD... Aug 31 2016
CTI BioPharma Reports Mixed Pacritinib Study Data, Stock Up Aug 30 2016
CTI BioPharma Meets One Of Two Endpoints In Phase 3 Trial Aug 29 2016
CTI BioPharma Announces Top-Line Results From PERSIST-2 Phase 3 Trial Of Pacritinib For High-Risk... Aug 29 2016
CTI BIOPHARMA CORP Financials Aug 13 2016
BrainStorm Cell Therapeutics Reports Second Quarter 2016 Financial Results and Provides Corporate... Aug 11 2016
CTI BioPharma reports 2Q loss Aug 04 2016
CTI BioPharma reports 2Q loss Aug 04 2016
CTI BIOPHARMA CORP Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Aug 04 2016
CTI BioPharma Reports Second Quarter 2016 Financial Results Aug 04 2016
CTI BIOPHARMA CORP Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD... Jul 28 2016
ETF’s with exposure to CTI BioPharma Corp. : July 20, 2016 Jul 20 2016
CTI BIOPHARMA CORP Files SEC form 8-K, Results of Operations and Financial Condition, Regulation FD... Jun 30 2016
ETF’s with exposure to CTI BioPharma Corp. : June 27, 2016 Jun 27 2016
Surging Earnings Estimates Signal Good News for CTI BioPharma (CTIC) Jun 10 2016
Should CTI BioPharma (CTIC) Be On Your Radar Now? Jun 08 2016
Long-Term Follow Up Data For Pacritinib Presented At 2016 ASCO Annual Meeting Jun 07 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)